+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Route of Administration, Distribution Channel, Therapeutic Application, End-user - Global Forecast 2025-2030- Product Image
Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Route of Administration, Distribution Channel, Therapeutic Application, End-user - Global Forecast 2025-2030- Product Image
Sale

Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Route of Administration, Distribution Channel, Therapeutic Application, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977713
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The injectable drug delivery market is experiencing a period of accelerated innovation, transforming both device technologies and healthcare delivery models. Senior executives looking to navigate new growth areas will find this sector characterized by evolving patient needs, digital integration, and critical operational challenges requiring strategic focus.

Market Snapshot: Injectable Drug Delivery Market Overview

The Injectable Drug Delivery Market grew from USD 640.93 billion in 2024 to USD 688.23 billion in 2025. It is expected to continue growing at a CAGR of 7.64%, reaching USD 997.45 billion by 2030. Market development is fueled by advances in patient-centric device design, regulatory shifts, and increased demand for biologic therapies. This growth highlights a dynamic environment where stakeholders must respond to rapidly evolving technologies and regulatory initiatives.

Scope & Segmentation

This report delivers a detailed analysis of the injectable drug delivery landscape, carefully segmenting the market to provide actionable insights on current and emerging opportunities:

  • Device Types: Conventional injection devices, self-injection platforms, including autoinjectors, needle-free injectors, pen injectors, and wearable injectors
  • Usability: Disposable and reusable systems with distinct profiles for contamination control and cost-effectiveness
  • Routes of Administration: Intradermal, intramuscular (IM), intravenous (IV), and subcutaneous (SC) delivery tailored for vaccine, acute, and chronic therapies
  • Distribution Channels: Hospital pharmacies, retail pharmacies, and online pharmacies to address diverse procurement models
  • Therapeutic Applications: Autoimmune diseases, cancer, chronic diseases, hormonal therapies, and infectious diseases
  • End-users: Home care settings, hospitals and clinics, pharmaceutical and biotech companies, and research laboratories
  • Regional Analysis: Key geographic coverage includes North and Latin America, Europe, the Middle East, Africa, and Asia-Pacific, capturing nuances in healthcare infrastructure and policy environments
  • Industry Players: Comprehensive insights on leaders such as AbbVie Inc., Amgen Inc., Becton, Dickinson and Company, Eli Lilly and Company, and others

Key Takeaways for Senior Decision-Makers

  • Innovation in device engineering centers on user-friendly design, digital connectivity, and scalable manufacturing for therapeutic differentiation.
  • Wearable and needle-free injector categories are reshaping chronic disease management, supporting patient adherence, and reducing clinical burden.
  • Segmentation by device types and usability reveals that both single-use and reusable systems play critical roles in meeting operational and sustainability goals.
  • Integrated procurement, engineering, and compliance teams are essential to balance cost management and regulatory standards across diverse supply chains.
  • Leading companies are utilizing strategic alliances and licensing to expand into high-value biologic therapies, leveraging shared regulatory and manufacturing resources.
  • Adaptability to regional healthcare policy variations, such as reimbursement models and infrastructure readiness, is crucial for successful market penetration.

Tariff Impact: U.S. Policy Environment

The evolving United States tariff regime in 2025 is reshaping cost structures and supplier strategies for injectable drug delivery. Adjusted duties on materials and components are prompting manufacturers to reassess sourcing, embrace nearshoring, and internalize critical operations. This shift demands agile operational planning, robust scenario analysis, and continued innovation in sourcing to ensure competitiveness and resilience across geographies.

Methodology & Data Sources

The analysis synthesizes secondary research from scientific publications, patents, and regulatory documents with primary interviews involving clinicians, procurement executives, and patient advocates. Quantitative surveys and validation workshops, combined with proprietary industry data, underpin the report's integrity and actionable insight.

Injectable Drug Delivery Market: Why This Report Matters

  • Offers decision-ready intelligence for targeting expansion, product development, and investment strategies, leveraging critical market segmentation.
  • Arms leaders with practical recommendations to foster cross-sector partnerships and sustainable supply chain resilience amid cost and compliance pressures.
  • Delivers a forward-looking view on how patient expectations, regional policy, and digital integration will affect future product and operational roadmaps.

Conclusion

Leaders equipped with insights on market shifts, technology trends, and regional variance can position their organizations to capture value in this evolving landscape. Strategic adaptation and patient-centered design will define tomorrow’s competitive edge in injectable drug delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of auto-injectors and prefilled syringes contributing to market growth
5.2. Integration of smart technology and IoT in injectable drug delivery systems enhancing real-time monitoring
5.3. Emergence of wearable injectors enabling sustained release and improved patient adherence
5.4. Increasing demand for biologics and biosimilars driving innovation in injectable devices
5.5. Focus on personalized medicine fueling development of tailored injectable delivery solutions
5.6. Regulatory updates shaping safety standards and approval processes for injectable devices
5.7. Expanding applications of injectable drug delivery in oncology and chronic disease management sectors
5.8. Growth in home healthcare settings boosting preference for user-friendly injectable drug delivery methods
5.9. Collaborations between pharmaceutical companies and device manufacturers accelerating new product launches
5.10. Advancements in needle-free injectable drug delivery technologies revolutionizing patient compliance and comfort
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Injectable Drug Delivery Market, by Device Type
8.1. Introduction
8.2. Conventional Injection Devices
8.3. Self-injection Devices
8.3.1. Autoinjectors
8.3.2. Needle-free Injectors
8.3.3. Pen Injectors
8.3.4. Wearable Injectors
9. Injectable Drug Delivery Market, by Usability
9.1. Introduction
9.2. Disposable
9.3. Reusable
10. Injectable Drug Delivery Market, by Route of Administration
10.1. Introduction
10.2. Intradermal
10.3. Intramuscular (IM)
10.4. Intravenous (IV)
10.5. Subcutaneous (SC)
11. Injectable Drug Delivery Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.3. Online Pharmacies
12. Injectable Drug Delivery Market, by Therapeutic Application
12.1. Introduction
12.2. Autoimmune Diseases
12.3. Cancer
12.4. Chronic Diseases
12.5. Hormonal Therapies
12.6. Infectious Diseases
13. Injectable Drug Delivery Market, by End-user
13.1. Introduction
13.2. Home Care Settings
13.3. Hospitals & Clinics
13.4. Pharmaceutical & Biotech Companies
13.5. Research Laboratories
14. Americas Injectable Drug Delivery Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Injectable Drug Delivery Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Injectable Drug Delivery Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Amgen Inc.
17.3.3. Antares Pharma by Halozyme Therapeutics
17.3.4. Becton, Dickinson and Company
17.3.5. Cipla Limited
17.3.6. Dr. Reddy’s Laboratories Ltd.
17.3.7. Eli Lilly and Company
17.3.8. Emperra GmbH
17.3.9. Enable Injections LLC
17.3.10. F. Hoffman - La Roche Ltd.
17.3.11. GlaxoSmithKline plc
17.3.12. Insulet Corporation
17.3.13. Johnson & Johnson Services, Inc.
17.3.14. Medtronic PLC
17.3.15. Novo Nordisk A/S
17.3.16. Pfizer, Inc.
17.3.17. Ravimed Sp. z o.o.
17.3.18. Recipharm AB
17.3.19. Sanofi S.A.
17.3.20. Stevanato Group
17.3.21. Sun Pharmaceutical Industries Ltd.
17.3.22. Tandem Diabetes Care
17.3.23. Teva Pharmaceutical Industries Ltd.
17.3.24. West Pharmaceutical Services, Inc.
17.3.25. Wilhelm Haselmeier GmbH & Co. KG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INJECTABLE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INJECTABLE DRUG DELIVERY MARKET: RESEARCHAI
FIGURE 28. INJECTABLE DRUG DELIVERY MARKET: RESEARCHSTATISTICS
FIGURE 29. INJECTABLE DRUG DELIVERY MARKET: RESEARCHCONTACTS
FIGURE 30. INJECTABLE DRUG DELIVERY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INJECTABLE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INTRADERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INTRAMUSCULAR (IM), BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INTRAMUSCULAR (IM), BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SUBCUTANEOUS (SC), BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SUBCUTANEOUS (SC), BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 114. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 115. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 116. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 117. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 122. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 123. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 130. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 131. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 132. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 133. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 209. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 212. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 213. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 214. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 215. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 228. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 229. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 230. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 231. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 257. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 260. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 261. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 262. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 263. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 268. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 269. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 276. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 277. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 278. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 279. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 284. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 285. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARA

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Injectable Drug Delivery market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Antares Pharma by Halozyme Therapeutics
  • Becton, Dickinson and Company
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • Emperra GmbH
  • Enable Injections LLC
  • F. Hoffman - La Roche Ltd.
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Ravimed Sp. z o.o.
  • Recipharm AB
  • Sanofi S.A.
  • Stevanato Group
  • Sun Pharmaceutical Industries Ltd.
  • Tandem Diabetes Care
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 688.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 997.45 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030 - Product Image

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030

  • Report
  • 967 Pages
  • Global
From
Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Anesthetics, Anti-Infective Drugs, Blood Factors / Coagulation), Category, Route Of Administration, Therapeutic Applications, End Users - Global Forecast 2025-2030 - Product Image

Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Anesthetics, Anti-Infective Drugs, Blood Factors / Coagulation), Category, Route Of Administration, Therapeutic Applications, End Users - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Injectable Medical Consumables Market by Product Type (Infusion Sets, Injector Pens, IV Catheters), End User (Ambulatory Care, Clinics, Diagnostic Centers), Application, Distribution Channel, Material - Global Forecast 2025-2030 - Product Image

Injectable Medical Consumables Market by Product Type (Infusion Sets, Injector Pens, IV Catheters), End User (Ambulatory Care, Clinics, Diagnostic Centers), Application, Distribution Channel, Material - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Injectable Drug Delivery Devices Market Size, Share and Trends Analysis Report by Product (Devices, Formulations), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders), End-use (Hospitals, Homecare Settings), and Region 2024-2030 - Product Image

Injectable Drug Delivery Devices Market Size, Share and Trends Analysis Report by Product (Devices, Formulations), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders), End-use (Hospitals, Homecare Settings), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Injectable Drug Delivery Devices Market Report 2025 - Product Image

Injectable Drug Delivery Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.